On May 14, 2021, Cumberland Pharmaceuticals Inc. announced that its Board of Directors has appointed John Hamm as the Company’s Senior Director Finance & Accounting and Chief Financial Officer effective May 17, 2021. Mr. Hamm joined the Company on June 3, 2019 and assumed expanded responsibilities as the Director, Corporate Development on January 1, 2020. Mr. Hamm has over 25 years of finance and accounting experience, with a majority in the health care industry. He previously held the positions of Chief Operating Officer and Chief Financial Officer, Pharmacy at HealthSpring Inc., a managed care organization currently operating as Cigna-HealthSpring. Prior to that he was Vice President Finance at Emdeon Business Services. Emdeon Inc., a healthcare technology firm now operates as Change Healthcare Inc., a NASDAQ listed company with over $3 billion in annual revenue. Mr. Hamm, age 65 has a Bachelor of Science in Business Administration with a minor in Accounting from Wheeling University. He earned his Master’s in Business Administration with an emphasis in Accounting from the University of West Virginia. He is a Certified Management Accountant (CMA) and Certified Financial Manager (CFM). Mr. Hamm also assumes the role of Principal Financial Officer and Principal Accounting Officer of Cumberland. Michael Bonner, who has been serving as the Company’s Senior Director Finance & Accounting and Chief Financial Officer will transition out of that role effective May 17, 2021, as he pursues other interests outside of the Company. Mr. Bonner will continue to serve as a consultant to the Company. Mr. Hamm’s new employment agreement is included as an exhibit to this Form 8-K.